In Madagascar, cataracts are the cause of a mounting public health crisis, as more than two hundred thousand people are blind or visually impaired, in a nation of 28 million. While many cases of cataract blindness can be resolved through cataract surgery, the…
Cataract continues to be the world’s leading cause of Blindness in 2021, with 100 million visually impaired people. Of those, 17 million are bilaterally blind, and 83 million have moderate to severe vision loss. With cataract surgery, those blind and severely visually…
On June 10, 2020, Dr. Van Lansingh, HelpMeSee Chief Medical Officer, participated in a United Nations (UN) High-Level Political Forum virtual panel entitled “Vision for Everyone as a Catalyst for the Decade of Action.” The meeting was convened by the Friends of Vision…
Today, HelpMeSee and Eye Hospital Wenzhou Medical University (EH-WMU) in China inaugurated the Sclerocorneal Tunnel Construction Course (STCC) to their first class of ophthalmology residents. STCC incorporates surgical skills instruction and practice utilizing two…
In China, many blind live in rural areas, but most of the eye doctors live in urban areas, which means most of the cataract patients cannot access treatment timely. According to statistics, there are approximately 17 million people in China suffering from moderate to…
The International Society of Small Incision Cataract Surgeons (ISMSICS) has named Dr. M.S. Ravindra as the first recipient of the Dr. Jatin Shah Award for Excellence in Manual Small Incision Cataract Surgery (MSICS). The award was presented in a ceremony to Dr….
During a ceremony at the Comprehensive Cataract Conference (CCC), the International Society of Manual Small Incision Cataract Surgeons (ISMSICS) presented Appasamy Associates with the Excellence in Ophthalmic Manufacturing Award.The award was given in recognition for…
HelpMeSee has signed a 5-year agreement with The International Society of Manual Small Incision Cataract Surgeons (ISMSICS) to become a global sponsor of the Comprehensive Cataract Conferences (CCC) to promote safe cataract surgeries for eliminating the backlog of…
The International Society of Manual Small Incision Cataract Surgeons (ISMSICS) and HelpMeSee jointly announce a series of events for the upcoming Comprehensive Cataract Conference 2017 (CCC 2017), including demonstrations of HelpMeSee’s simulation-based training…
HelpMeSee presented the first US public demonstration of the breakthrough Eye Surgery Simulator at the 41st Annual Meeting of the Christian Ophthalmology Society (COS) in Lake Junaluska, North Carolina. This annual meeting hosted the largest attendance in…
HelpMeSee, Inc.
1 Evertrust Plaza, Suite 308, Jersey City, NJ 07302
1 Evertrust Plaza, Suite 308,
Jersey City, NJ 07302
HelpMeSee est une organisation à but non lucratif de type 501(c)(3) enregistrée aux États-Unis. La mission de HelpMeSee est d'éradiquer la cécité évitable due à la cataracte dans le monde entier. Nous y parvenons grâce à un programme innovant et évolutif de formation à la chirurgie de la cataracte basée sur la simulation. Notre programme couvre la chirurgie manuelle de la cataracte par petite incision (MSICS), le cours de formation par simulation à la phacoémulsification, le cours de formation par simulation à la suture et des cours supplémentaires. Ces offres permettent aux professionnels des soins oculaires d'affiner leurs compétences, de maîtriser les procédures vitales et d'exceller en ophtalmologie. Nous sommes déterminés à restaurer la vision des personnes souffrant de déficiences visuelles graves et de cécité induite par la cataracte dans le monde entier.
Numéro d'identification fiscale : 27-3207754
Charte des droits du donneur | Divulgation financière | Conditions générales de Link Training Services | Conditions générales d'utilisation du simulateur SBLS | Partage des données de l'application et consentement | Code mondial d'éthique et de conduite | Avis de traitement des données du site web | Conditions d'utilisation du site web | Plan du site HTML | Dossier de presse
©2025 HelpMeSee - Tous droits réservés
French 
English 
Spanish